AMANTADINE DEVELOPS DRUG TOXIC SYMPTOM IN A PATIENT WITH LATE EFFECTS OF CEREBRAL INFARCTION

• At: AbuDhabi (United Arab Emirates) (2019)
• Type: Poster
• Poster code: POS-HMIS-032
• By: WATANABE, Yoshiteru (Tohoku Medical and Pharmaceutical University Hospital, Pharmacy, Japan)
• Co-author(s): Yoshiteru Watanabe: Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan
  Takashi Uno: Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan
  Miho Utsumi: Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan
  Masashi Nakamura: Neurology, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan
  Kensuke Usui: Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan
  Kouji Okada: Pharmacy, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan
  Eiji Suzuki: Psychiatry, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan
  Ichiro Nakashima: Neurology, Tohoku Medical and Pharmaceutical University Hospital, Sendai, Japan
  
• Abstract:

  Background

  Amantadine acts on dopamine neurons and is used to treat the symptoms of Parkinson's disease. This drug improves the spontaneity decrease with late effects of cerebral infarction.

  Methods

  A 70s-year-old female patient with cerebral infraction was hospitalized in our hospital and she was treated for the acute phase.

   

  Results

  On the

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login